This article was originally published in RAJ Devices
FDA sets up task force to look at compliance in tissue manufacture
You may also be interested in...
The 10-year partnership brings Arcus up-front funding with ample earnout opportunities, while Gilead gets extensive opt-in rights and an equity stake it can increase – and potentially a wholly owned dual checkpoint combination.
US and Europe led in 2019 sales of omega-3-fortified products worldwide, a market valued at $44bn that has extended beyond supplements and baby formulas to include foods, beverages and pet food, says GOED in report released 26 May. As the US market is ‘mature,’ its sales growth is expected at 5.8% in 2021, while sales of less mature markets such as Asia (excluding China) is anticipated to climb 12.6%.
CVS Caremark's Lotvin reports increased US payer interest in more comprehensive drug management solutions and that some payers are asking about dropping coverage for drug categories.